Tarsus Pharmaceuticals (TARS) Form 144 Filed on June 15

AI Summary

Tarsus Pharmaceuticals (TARS) filed Form 144 on June 15, indicating a potential sale of shares by insiders. Form 144 is typically used to notify the SEC about the intention to sell restricted or control securities. This event may influence market perceptions regarding the liquidity and activity of insider trades. Investors often monitor such filings for insights into management confidence and stock performance, making this filing notable in the context of TARS's stock liquidity.